Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
about
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of variation in imm ...... of clear cell ovarian cancer.
@en
Assessment of variation in imm ...... of clear cell ovarian cancer.
@nl
type
label
Assessment of variation in imm ...... of clear cell ovarian cancer.
@en
Assessment of variation in imm ...... of clear cell ovarian cancer.
@nl
prefLabel
Assessment of variation in imm ...... of clear cell ovarian cancer.
@en
Assessment of variation in imm ...... of clear cell ovarian cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Assessment of variation in imm ...... of clear cell ovarian cancer.
@en
P2093
Agnieszka Timorek
Alice S Whittemore
Alice W Lee
Alyssa Clay
Andreas du Bois
Andrew Berchuck
Anna M van Altena
Arto Leminen
Barbara Perkins
P2860
P304
69097-69110
P356
10.18632/ONCOTARGET.10215
P407
P50
P577
2016-06-21T00:00:00Z